Hardman Johnston Global Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-106,365
Closed -$17M 77
2015
Q1
$17M Buy
106,365
+30
+0% +$4.72K 1.03% 38
2014
Q4
$16.9M Sell
106,335
-665
-0.6% -$104K 0.92% 38
2014
Q3
$15M Sell
107,000
-4,130
-4% -$539K 0.83% 38
2014
Q2
$13.2M Sell
111,130
-1,930
-2% -$223K 0.7% 43
2014
Q1
$13.9M Sell
113,060
-2,000
-2% -$243K 0.81% 41
2013
Q4
$13.1M Buy
115,060
+280
+0.2% +$31.9K 0.86% 40
2013
Q3
$12.8M Sell
114,780
-310
-0.3% -$33.6K 0.86% 39
2013
Q2
$11.4M Buy
+115,090
New +$11.9M 0.78% 41

Other funds holding AMGN

Hardman Johnston Global Advisors's AMGN Position: Q2 2015 in Review

Hardman Johnston Global Advisors sold out of Amgen (AMGN) in Q2 2015, closing a stake of 106,365 shares — an estimated $17M sold.

Hardman Johnston Global Advisors first reported a position in AMGN in Q2 2013 and held it in 8 quarters. The position peaked at $17M in Q1 2015. 1,366 funds tracked by Wall St. Rank hold AMGN as of Q2 2015.

  • Hardman Johnston Global Advisors reported no remaining Amgen position as of Q2 2015 after selling out during the quarter.
  • Hardman Johnston Global Advisors sold 106,365 Amgen shares in Q2 2015, an estimated $17M.
  • Hardman Johnston Global Advisors first reported a position in Amgen in Q2 2013 and held it in 8 quarters.
  • Hardman Johnston Global Advisors's Amgen position peaked at $17M in Q1 2015.
  • 1,366 funds tracked by Wall St. Rank held Amgen as of Q2 2015.

Based on Hardman Johnston Global Advisors's 13F filing for Q2 2015, filed 11 Aug 2015.